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Inulin clearance (C1) has long been accepted as the standard
method for measurement of glomerular filtration rate (GFR) in
normal subjects [1—3]. In renal transplant recipients and donors,
however, Rosenbaum et al [41 showed a significant decrease in
standard C1,, relative to the standard clearances of other mark-
ers of GFR such as iothalamate (C10) and creatinine (Ccr). This
phenomenon was seen within a week of transplantation and
persisted in one patient up to 14 years. Heller, Horacek, and
Hollyova [51 reported a similar discrepancy in transplanted
dogs but only as a transient phenomenon. At 6 months after
transplantation C1,, and CC,. in these dogs were identical. To our
knowledge, there is no corresponding information in children.
Other widely used methods of estimating GFR, such as
constant infusion clearances of inulin and iothalamate [6], the
51Cr EDTA single injection method (EDTA GFR) using a single
compartmental analysis [7, 8], and the GFR predicted from a
height/plasma creatinine formula [9], have not been studied in
transplanted children.
The purpose of this study is to compare these methods of
measuring GFR in the follow-up of children after renal
transplantation.
Methods. Eighteen children, aged 6 to 16, were studied 1
month to 8 years after transplantation. Standard and infusion
clearances of inulin and iothalamate were measured in ten
patients for validation of the infusion technique, which avoids
the need for urine collection [6]; endogenous Cc. was also
measured. Thirty-one infusion clearances of inulin and iothala-
mate were performed; eight children were studied more than
once. EDTA GFR was performed in 15 patients simultaneously
with the clearance of inulin and iothalamate.
Priming doses of 1 mi/kg of a solution containing 50 ml of 10%
inulin and 16 ml of nonradioactive sodium iothalamate (Conray
420) were given intravenously to obtain plasma levels of ap-
proximately 0.3 mg/ml of inulin and iodine. This was followed
by a constant infusion of the same solution at a rate calculated
to maintain constant blood levels. This rate was calculated on
the basis of the excretion rate of the markers predicted from the
height/creatinine formula. After a 90-mm equilibration period,
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three clearance periods were obtained. Collection periods var-
ied from 15 to 30 mm depending on the patient's ability to void.
Errors due to incomplete voiding were minimized by maintain-
ing urine flow rates in excess of 3 mI/mm throughout with
copious intake of water. Blood samples were taken at the
expected midpoint of each clearance period. The patients fasted
during the clearance periods and were in the supine position
except when voiding.
Urine and blood samples were analyzed for inulin by the
method of Heyrovsky [10], iothalamate by the fluorescent
excitation method [11], and creatinine on an automated analyz-
er using the reaction rate analysis of Cook [12]. All estimations
were performed in duplicate.
The formula C = (UV/P) was used for the calculation of
standard clearances, where C, U, and P are the clearance, urine
concentration, and plasma concentration, respectively, of the
substance used and V is the urine flow rate. Infusion clearances
were calculated using the constant infusion principle with the
formula, C = (IRIP) where I is the concentration of the marker
in the infusate and R the rate of infusion [6].
Clearance of EDTA was estimated by single compartmental
analysis of the plasma decay curve of the isotope following a
single, rapid intravenous injection [7, 8]. Predicted GFR was
calculated from the formula:
4OxhtxSAGFR (mllmin) =
PCr x 1.73
plasma creatinine concentration (imoles/l) [9].
Linear regression and the paired t test were used for statisti-
cal analysis. The protocol was approved by the Guy's Hospital
Ethical Commitee and informed consent was obtained from all
patients and their parents prior to the study.
Results. The intra- andinter-assay variations for the different
laboratory estimations are shown in Table 1. Results of the
creatinine assay have been published elsewhere [131.
The values of endogenous Cc,., standard C1,,, and C10, and
simultaneous infusion C1,, and C10 in the first ten patients are
shown in Table 2. Each value is expressed as the mean of three
clearance periods. The standard clearance values of creatinine,
inulin, and iothalamate did not differ significantly. The mean
ratios of Cc,. to C1,, and C10 to C1,, were 1.06 0.04 and 0.95
0.03. The relationships of Cc,. to C1,, and C10 to C1,, are shown in
Figure 1.
The infusion clearance values of inulin and iothalamate
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Plasma Urine Infusate
%
Inulin intra assay
inter assay
2.48
3.80
2.63
3.40
5.10
4.80
lothalamate intra assay
inter assay
1.30
2.50
1.80
2.90
0.70
1.16
agreed well with the respective standard clearance values. No
significant difference was found between infusion and standard
clearance values for either. The mean ratio of standard C1,/
infusion C1, and standard C10linfusion C10 were 1.07 0.05 and
1.04 0.05, respectively. These results are shown in Table 3.
In the 31 infusion clearances performed, a constant plasma
level (± 5%) was obtained for inulin and iothalamate after the
equilibration period in all but three instances; these three
studies were excluded. The clearances were calculated from the
mean of the three plasma values. The infusion clearance values
of iothalamate and inulin again did not differ significantly. The
mean ratio of infusion C10/infusion C1 was 1.00 0.02 (Table
3).
Although EDTA GFR correlated reasonably well with infu-
sion C1, and C10 (Fig. 2), inspection of the plot suggests an
overestimation of C10 at values greater than 40 mi/mm. This
impression is confirmed by a direct comparison of these higher
values, at which EDTA GFR is on the average 25% higher than
C10 (P < 0.02). The lower values are not significantly different.
The comparison of predicted GFR with both infusion inulin
and iothalamate clearance values showed significant differences
(P <0.01 by the paired t test in both instances). The mean ratio
of predicted GFR/C1 was 0.85 0.07 and predicted GFR/C10
was 0.85 0.06. The relationship of predicted GFR to C10 is
shown in Figure 3.
Discussion. The renal clearance of inulin (5,200 daltons),
measured by the standard (UV/P) method, has been accepted a
long time as the reference technique for measurement of GFR in
normal subjects [1—3]. However, inulin is a less than ideal
marker in practice, as it is only moderately soluble in water and
difficult to measure accurately in the laboratory; furthermore,
its validity has been questioned as a marker of GFR in the
transplanted kidney [4, 51. In addition, the standard clearance
method is difficult to use as a routine clinical procedure,
requiring as it does the collection of accurately timed urine
specimens. Therefore, we have compared other markers and
other clearance techniques with the standard inulin clearance in
transplanted children, (1) to determine whether or not simpler
methods are capable of yielding results sufficiently accurate for
clinical purposes and (2) to re-examine the proposition that
filtration of inulin may be restricted in the transplanted kidney.
We obtained excellent agreement between the clearances of
inulin, creatinine, and nonradioactive iothalamate measured by
standard methodology; the ratios C10/C1 (0.95 0.03) and Cr/
C1,. (1.06 0.04) were well within the reported ranges in normal
adults. We are unable to explain the striking discrepancy
between our results and those found in adults by Rosenbaum et
al [41; in our study the clearance of any of these three sub-
stances appears to give an estimate of GFR at least adequate for
clinical use. We believe that this is to be expected given the
results obtained by other investigators in studies of the renal
handling of creatinine [14, 151 and iothalamate [16—19] in
nontransplanted subjects.
In addition, we found that infusion clearance values in our
group of transplanted children correlated well with standard
clearance values for both inulin and iothalamate. A significant
difference was not found by the paired t test in both instances.
The mean ratio of standard C1,./infusion C1,. was 1.07 0.05 and
standard C10/infusion C10 was 1.04 0.05. These results
indicate that infusion clearance techniques measure GFR accu-
rately in children after renal transplantation. An important
factor in obtaining an accurate infusion clearance is the calcula-
tion of an appropriate rate of infusion following the loading dose
Table 1. Coefficient of variation of inulin and iothalamate assays 70'
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Fig. 1. Relationship of simultaneous standard iothalamate clearance(C,0) and standard creatinine clearance (Ce. to standard inulin clear-
ance (C1,,).
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Fig. 1. Relationship of simultaneous standard iothalamate clearance(C,0) and standard creatinine clearance (Ce. to standard inulin clear-
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Fig. 3. Relationship between GFR as estimated from the height/
creatinine formula and infusion iothalamate clearance.
significantly underestimated infusion clearance values of inulin
and iothalamate (P < 0.01). The mean ratio of predicted GFR/
C1,, was 0.85 0.07 and predicted GFR'C10 0.85 0.06. The
plot of predicted GFR versus C10 (Fig. 3) shows a considerable
scatter of values.
These results indicate that while the predicted GFR remains
useful as a rough estimate of GFR, it is significantly less precise
than the standard or infusion clearance methods in the follow-
up of children after renal transplantation. EDTA GFR overesti-
mates GFR measured by standard methods in patients with C10
>40 mllmin but agrees well when function is below this level; it
is likely that changes in GFR in a particular patient would be
reliably detected by this method [81. However, Car, performed
as described above, is the simplest of the formal clearance
methods examined, involving little or no loss of accuracy when
compared with C1, and C10, and is recommended as the method
of choice in clinical transplant care.
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